| Address:
|
5 GIRALDA FARMS
|
| City: |
MADISON |
|
State: |
NJ |
|
Zip Code: |
07940 |
| Telephone: |
973-660-5000 |
|
Description of Business
|
Primary SIC Code:
2834 |
| (As filed with the SEC)
|
|
|
Unless stated to the contrary, or unless the context otherwise requires,
references to "Wyeth," "the company," "our company," "our," or "us" in this
report include Wyeth and its subsidiaries.
Wyeth, a Delaware corporation, organized in 1926, is currently engaged in the
discovery, development, manufacture, distribution and sale of a diversified line
of products in three primary businesses: Wyeth Pharmaceuticals, which we refer
to as Pharmaceuticals, Wyeth Consumer Healthcare, which we refer to as Consumer
Healthcare, and Fort Dodge Animal Health, which we refer to as Animal Health.
Pharmaceuticals includes branded human ethical pharmaceuticals, biotechnology
products, vaccines and nutrition products. Principal Pharmaceuticals products
include neuroscience therapies, vaccines, musculoskeletal therapies, nutrition
products, gastroenterology drugs, anti-infectives, oncology therapies,
hemophilia treatments, immunological products and women's health care products. ... More ... |
| Date |
12-mos
Rolling EPS |
Dividend |
P/E
Ratio |
| There's no share overview data. |
Key Financial Ratios and Statistics |
FYE:
12/31 |
| Profitability |
2008 |
Leverage |
2008 |
| Net Inc/Comm Equity | 0.56 | Total Liab/Total Assets | 0.56 | | Net Inc/Total Assets | 0.10 | Total Liab/Inv Cap | 0.69 | | Net Inc/Inv Cap | 0.12 | Total Liab/Comm Equity | 3.14 | | Pretax Inc/Net Sales | 0.28 | Interest Coverage Ratio | 12.28 | | Net Inc/Net Sales | 0.19 | Curr Debt/Equity | 0.05 | | Cash Flow/Net Sales | 0.23 | LTD/Equity | 0.56 | | SG&A/NetSales | 0.30 | Total Debt/Equity | 0.61 |
| Asset Utilization
|
|
Liquidity |
|
| Net Receivables Turnover | 6.37 | Quick Ratio | 2.99 | | Inventory Turnover | 2.07 | Current Ratio | 3.43 | | Inventory Day Sales | 0.01 | Net Rec/Curr Assets | 0.16 | | Net Sales/Work Cap | 1.37 | Inv/Curr Assets | 0.13 | | Net Sales/PP&E | 2.04 | | |
Income Statement (Millions) |
| |
6/30/2009
|
3/31/2009
|
12/31/2008
|
9/30/2008
|
|
Total Revenues(Net Sales)
|
5,695.16
|
5,376.97
|
5,348.32
|
5,829.58
|
|
Cost of Goods Sold
|
1,564.96
|
1,380.89
|
1,430.35
|
1,571.47
|
|
Selling & Admin Exps
|
1,598.52
|
1,591.81
|
1,647.93
|
1,635.72
|
|
Operating Income
|
1,646.38
|
1,631.15
|
1,372.03
|
1,822.64
|
|
Interest Exp
|
187.01
|
65.31
|
557.61
|
4.18
|
|
Pretax Income
|
1,806.26
|
1,688.45
|
1,253.45
|
1,707.81
|
|
Other Income
|
346.90
|
122.61
|
439.02
|
-110.65
|
|
Net Income Bef Extraordinary ...
|
NA
|
NA
|
NA
|
NA
|
|
Net Income
|
1,272.02
|
1,198.16
|
960.39
|
1,138.41
|
|
Assets
|
6/30/2009
|
3/31/2009
|
12/31/2008
|
9/30/2008
|
|
Cash & Short Term Investments
|
15,936.38
|
16,668.03
|
14,545.27
|
14,172.98
|
|
Receivables - Total
|
3,928.68
|
3,631.96
|
3,646.44
|
3,919.22
|
|
Inventories - Total
|
3,337.47
|
3,053.62
|
2,996.43
|
2,968.80
|
|
Total Current Assets
|
25,592.60
|
23,739.10
|
23,481.34
|
23,392.19
|
|
Net Property, Plant & Equipment
|
11,199.23
|
10,981.03
|
11,198.21
|
11,080.78
|
|
Total Assets
|
45,619.10
|
43,998.39
|
44,031.72
|
43,183.60
|
|
Liabilities
|
|
|
|
|
|
Accounts Payable
|
5,935.52
|
5,396.35
|
5,937.18
|
6,162.26
|
|
Debt in Current Liabilities
|
917.09
|
852.74
|
913.25
|
1,041.16
|
|
Total Current Liabilities
|
6,852.61
|
6,249.09
|
6,850.42
|
7,203.41
|
|
Long-Term Debt
|
10,551.80
|
10,740.73
|
10,826.01
|
10,469.37
|
|
Total Liabilities
|
24,832.39
|
24,271.36
|
24,857.88
|
23,494.72
|
|
Stockholder's Equity
|
|
|
|
|
|
Minority Interest
|
NA
|
NA
|
NA
|
NA
|
|
Preferred Stock
|
0.02
|
0.02
|
0.02
|
0.02
|
|
Common Stock
|
444.72
|
444.15
|
443.85
|
443.82
|
|
Retained Earnings
|
14,076.24
|
13,625.36
|
12,868.80
|
11,910.87
|
|
Treasury Stock
|
NA
|
NA
|
NA
|
NA
|
|
Total Stockholders' Equity
|
20,786.71
|
19,727.03
|
19,173.84
|
19,688.88
|
|
Total Liabilities and Stockholders' Equity
|
45,619.10
|
43,998.39
|
44,031.72
|
43,183.60
|
Cash Flow Summary (Millions) |
|
Categories
|
6/30/2009
|
3/31/2009
|
12/31/2008
|
9/30/2008
|
|
Net Cash Provided by Operating Activities
|
1,481.30
|
1,080.69
|
1,539.25
|
1,862.10
|
|
Net Cash Provided by Investing Activities
|
-714.63
|
-1,750.87
|
-2,040.94
|
-620.14
|
|
Net Cash Provided by Financing Activities
|
-458.94
|
-484.57
|
-538.17
|
-447.23
|
Annual Summary Data (Millions) |
| Year |
Sales |
Net
Income |
EPS |
| 12/2004 | 17,358.03 | 1,234.00 | -- | | 12/2005 | 18,755.79 | 3,656.30 | -- | | 12/2006 | 20,350.66 | 4,196.71 | -- | | 12/2007 | 22,399.80 | 4,615.96 | -- | | 12/2008 | 22,833.91 | 4,417.83 | -- | | Growth Rates | 7.10 | 37.55 | -- |
| Type |
Date(Q,M) |
No.
Owners |
Shares
Held (000s) |
%
Own |
| There's no stock ownership data. |
|
Report Date :
10/19/2009
 Copyright
2009, EDGAR Online, Inc. All
rights reserved. Replication or redistribution of EDGAR Online, Inc. content is
expressly prohibited without the prior written consent of EDGAR Online, Inc.
EDGAR Online, Inc. shall not be liable for any errors or delays in the content,
or for any actions taken in reliance thereon.
|
|
|